BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.

Saved in:
Bibliographic Details
Title: BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.
Authors: Spikes LA; Pulmonary and Critical Care Medicine University of Kansas Medical Center Kansas City Kansas USA., Bajwa AA; Pulmonary Medicine Ascension St. Vincent's Hospital Southside Jacksonville Florida USA., Burger CD; Pulmonary Medicine Mayo Clinic Jacksonville Florida USA., Desai SV; Heart Failure and Transplantation Cardiology Ochsner Medical Center New Orleans Louisiana USA., Eggert MS; Pulmonary and Critical Care Medicine Sentara Heart Hospital Norfolk Virginia USA., El-Kersh KA; Pulmonary and Critical Care Medicine University of Nebraska Medical Center Omaha Nebraska USA., Fisher MR; Pulmonary and Critical Care Medicine Emory University School of Medicine Atlanta Georgia USA., Johri S; Pulmonary and Critical Care Medicine Henrico Doctors' Hospital and Bon Secours St. Francis Medical Center Richmond Virginia USA., Joly JM; Cardiology, Heart Failure and Transplantation Cardiology University of Alabama at Birmingham Birmingham Alabama USA., Mehta J; Pulmonary and Critical Care Medicine The Cleveland Clinic Weston Florida USA., Palevsky HI; Pulmonary Medicine University of Pennsylvania Philadelphia Pennsylvania USA., Ramani GV; Cardiology University of Maryland School of Medicine Baltimore Maryland USA., Restrepo-Jaramillo R; Pulmonology and Critical Care Medicine University of South Florida College of Medicine Tampa Florida USA., Sahay S; Pulmonary Hypertension and Pulmonary Critical Care Houston Methodist Hospital Houston Texas USA., Shah TG; Pulmonary and Critical Care Medicine University of Texas Southwestern Medical Center Dallas Texas USA., Deng C; Clinical Product Development United Therapeutics Corporation Research Triangle Park North Carolina USA., Miceli M; Global Medical Affairs United Therapeutics Corporation North Carolina Research Triangle Park USA., Smith P; Clinical Product Development United Therapeutics Corporation Research Triangle Park North Carolina USA., Shapiro SM; Pulmonology, Greater Los Angeles VA Healthcare System Cardiology Section, and David Geffen UCLA School of Medicine Los Angeles California USA.
Source: Pulmonary circulation [Pulm Circ] 2022 Apr 07; Vol. 12 (2), pp. e12063. Date of Electronic Publication: 2022 Apr 07 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101557243 Publication Model: eCollection Cited Medium: Print ISSN: 2045-8932 (Print) Linking ISSN: 20458932 NLM ISO Abbreviation: Pulm Circ Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2045-8932
DOI:10.1002/pul2.12063